Pamela Stephenson

Corporate Officer/Principal bei DISC MEDICINE, INC.

Vermögen: 1 Mio $ am 31.05.2024

56 Jahre

Health Technology

Consumer Services

Aktive Positionen von Pamela Stephenson

Unternehmen	Position	Beginn	Ende
DISC MEDICINE, INC.	Corporate Officer/Principal	26.02.2024	-

Unternehmen	Position	Beginn	Ende
ZYNERBA PHARMACEUTICALS, INC.	Direktor/Vorstandsmitglied	19.02.2019	10.10.2023
ZYNERBA PHARMACEUTICALS, INC.	Independent Dir/Board Member	19.02.2019	10.10.2023
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	01.07.2008	01.03.2019
ALBIREO PHARMA, INC.	Corporate Officer/Principal	25.03.2019	-

Brown University	Undergraduate Degree
Boston University School of Public Health	Graduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Director/Board Member	1
Independent Dir/Board Member	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
ZYNERBA PHARMACEUTICALS, INC.	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
DISC MEDICINE, INC.	Health Technology

Private Unternehmen	1
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.	Health Technology

Private Unternehmen

Health Technology